Within each D’Amico risk category, African-American and Hispanic prostate cancer patients were less likely to receive definitive treatment than white patients.
Read the source article at Renal & Urology News
Categories: Market Trends, News
Within each D’Amico risk category, African-American and Hispanic prostate cancer patients were less likely to receive definitive treatment than white patients.
Read the source article at Renal & Urology News
Categories: Market Trends, News